SCHEDULE: RTW Investments Discloses Stake in Century Therapeutics

RTW Investments, LP and Roderick Wong have reported a beneficial ownership of 7.1% in Century Therapeutics, Inc. common stock.

Summary

• RTW Investments, LP, an investment adviser, and Roderick Wong, its Managing Partner and Chief Investment Officer, have jointly filed a Schedule 13G.
• This filing indicates their beneficial ownership of 13,043,478 shares of Century Therapeutics, Inc. common stock.
• This ownership represents 7.1% of the class of securities.
• The filing assumes the exercise of warrants held by RTW Investments, LP to purchase 4,347,826 shares.
• The total shares outstanding used for calculation was 179,722,750 as of February 28, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating a significant investment by RTW Investments, but without direct company performance updates.

Positives

• RTW Investments, LP and Roderick Wong have established a significant stake, holding 7.1% of Century Therapeutics, Inc. common stock.
• The ownership stake is based on the assumption of warrant exercises, indicating a potential for increased future ownership.

Risks

• The filing does not explicitly mention any risks, but the nature of investment advisory and potential warrant exercises implies market and investment-specific risks.

Future Outlook

The filing does not contain forward-looking statements or guidance from the company. The reported ownership percentage assumes the exercise of warrants, which is a forward-looking action by the reporting persons.

Industry Context

StockSavvy.ai notes that significant stake disclosures by investment firms like RTW Investments often signal strong conviction in a company's future prospects within the biotechnology sector, particularly for companies like Century Therapeutics focused on cell and gene therapy.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an investment firm can be interpreted as a positive signal of confidence in the company's value and future prospects, potentially influencing market perception.
• Company Management: The increased scrutiny from a substantial institutional investor may influence strategic decisions and corporate governance practices.

Next Steps

• RTW Investments, LP and Roderick Wong will file amendments to this statement as necessary.
• The RTW Funds have the right to receive dividends from, or direct the proceeds from the sale of, the Shares.

Key Dates

Recommendation

The filing indicates a significant investment by RTW Investments, suggesting confidence in Century Therapeutics. However, as this is a Schedule 13G and not a performance report, it lacks direct company operational or financial results. Therefore, a 'hold' recommendation is appropriate, pending further company-specific performance data.

Keywords

Century Therapeutics, RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing